Insight

Henry Rodriguez: Unraveling the mysteries of small cell lung cancer

Photo taken from Henry Rodriguez/LinkedIn

Feb 26, 2024, 11:16

Henry Rodriguez: Unraveling the mysteries of small cell lung cancer

Henry Rodriguez, Founding Director of the Office of Cancer Clinical Proteomics Research at the NCI, shared on LinkedIn:

“Exciting news in SCLC! A collaborative study by the National Cancer Institute (NCI), ICPC (International Cancer Proteogenome Consortium) China Team, and CPTAC (Clinical Proteomic Tumor Analysis Consortium) has published a comprehensive study, unraveling the mysteries of small cell lung cancer.

Their proteogenomic insights could pave the way for subtype-specific therapies. Kudos!”

View additional information.
Source: Henry Rodriguez/LinkedIn

cancer Cancer Moonshot Cancer research Clinical Proteomic Tumor Analysis Consortium CPTAC Henry Rodriguez ICPC International Cancer Proteogenome Consortium Lung cancer National Cancer Institute NCI OncoDaily Oncology proteogenomics SCLC small cell lung cancer

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage